Zevra Therapeutics, Inc.ZVRANASDAQ
LOADING
|||
Switch Symbol:
Gross Profit Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year gross profit growth rate
Latest
81.53%
↑ 28% above average
Average (39q)
63.90%
Historical baseline
Range
High:667.03%
Low:-105.44%
Volatility
1208.9%
High variability
| Period | Value |
|---|---|
| Q3 2025 | 81.53% |
| Q2 2025 | -29.15% |
| Q1 2025 | 78.48% |
| Q4 2024 | 667.03% |
| Q3 2024 | 58.90% |
| Q2 2024 | 447.50% |
| Q1 2024 | -98.47% |
| Q4 2023 | 279.17% |
| Q3 2023 | -64.70% |
| Q2 2023 | 155.42% |
| Q1 2023 | 40.21% |
| Q4 2022 | -20.38% |
| Q3 2022 | 118.82% |
| Q2 2022 | -68.44% |
| Q1 2022 | 56.84% |
| Q4 2021 | 28.40% |
| Q3 2021 | -82.11% |
| Q2 2021 | -1.18% |
| Q1 2021 | 369.86% |
| Q4 2020 | 22.91% |
| Q3 2020 | -69.28% |
| Q2 2020 | 339.41% |
| Q1 2020 | 350.62% |
| Q4 2019 | -105.44% |
| Q3 2019 | 0.00% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |
| Q4 2017 | 0.00% |
| Q3 2017 | 0.00% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |
| Q4 2016 | 0.00% |
| Q3 2016 | 0.00% |
| Q2 2016 | 0.00% |
| Q1 2016 | 0.00% |
| Q4 2015 | 0.00% |